Evidence map›Paper›PMID 40413821›Full record

ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2025

Comparison of liver bile acid profiles in chronic alcohol feeding and NIAAA binge-on-chronic alcohol feeding mouse models.

Jing Feng, Liqing He, Xipeng Ma, Xinmin Yin, Eugene G Mueller, Zhanxiang Zhou, Wenke Feng, Craig J McClain, Xiang Zhang

Abstract readComparative Study
In one paragraph

Article in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing FengDepartment of Chemistry, University of Louisville, Louisville, KY 40292, USA; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA; Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, KY 40208, USA.
Liqing HeDepartment of Chemistry, University of Louisville, Louisville, KY 40292, USA; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA; Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, KY 40208, USA.
Xipeng MaDepartment of Chemistry, University of Louisville, Louisville, KY 40292, USA; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA; Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, KY 40208, USA.
Xinmin YinDepartment of Chemistry, University of Louisville, Louisville, KY 40292, USA; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA; Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, KY 40208, USA.
Eugene G MuellerDepartment of Chemistry, University of Louisville, Louisville, KY 40292, USA.
Zhanxiang ZhouCenter for Translational Biomedical Research, University of North Carolina at Greensboro, Greensboro, NC 27412, USA; Department of Nutrition, University of North Carolina at Greensboro, Greensboro, NC 27412, USA.
Wenke FengDepartment of Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Craig J McClainAlcohol Research Center, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, USA; Department of Medicine, University of Louisville, Louisville, KY 40202, USA; Robley Rex Louisville VAMC, Louisville, KY 40206, USA.
Xiang ZhangDepartment of Chemistry, University of Louisville, Louisville, KY 40292, USA; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology COBRE, University of Louisville, Louisville, KY 40202, USA; Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, KY 40208, USA; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, USA. Electronic address: xiang.zhang@louisville.edu.

Funding

Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver diseaseP20GM113226 · NIGMS · UNIVERSITY OF LOUISVILLE · PI GHARE, SMITA S · 2016 to 2025
$24.1M
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ InjuryP50AA024337 · NIAAA · UNIVERSITY OF LOUISVILLE · PI Irina A. Kirpich · 2016 to 2026
$17.9M
Integrated therapies for alcohol use and ALD (ITAALD) Network -UofL Clinical CenterU01AA026980 · NIAAA · UNIVERSITY OF LOUISVILLE · PI CRAIG J. MCCLAIN, Ashwani K Singal · 2018 to 2026
$2.9M
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver diseaseR01AA030424 · NIAAA · UNIVERSITY OF LOUISVILLE · PI WENKE FENG · 2022 to 2026
$2.6M
Lipid metabolites can both potentiate and treat alcoholic hepatitisU01AA026936 · NIAAA · UNIVERSITY OF LOUISVILLE · PI JOSHI-BARVE, SWATI, MCCLAIN, CRAIG J. · 2018 to 2022
$1.2M
Ultra Performance Liquid Chromatography High Resolution High Mass Accuracy Mass SpectrometerS10OD020106 · OD · UNIVERSITY OF LOUISVILLE · PI ZHANG, XIANG · 2015 to 2015
$600k
RNA Modification Changes in Alcohol-Associated Liver DiseaseR21AA031563 · NIAAA · UNIVERSITY OF LOUISVILLE · PI HE, LIQING · 2024 to 2025
$400k
Pilot Trial UO1 DUR-928U01AA026934 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2018 to 2022
$356k
BLRD VA I01 BX002996NIAAA NIH HHS P50 AA024337NIAAA NIH HHS R01 AA030424NIAAA NIH HHS R21 AA031563NIAAA NIH HHS U01 AA026934NIAAA NIH HHS U01 AA026936NIAAA NIH HHS U01 AA026980NIGMS NIH HHS P20 GM113226NIH HHS S10 OD020106
6 · The paper itself

Abstract

Alcohol-associated liver disease (ALD) is associated with disturbances in bile acid (BA) metabolism. Several mouse models have been established to mimic human ALD in the clinical setting for mechanistic investigations, and differences in BA metabolism between these models have not been systematically studied. We quantified BA alterations by liquid chromatography-mass spectrometry (LC-MS) in the livers of two widely used mouse models: the chronic Lieber-DeCarli ethanol diet (CLD) model and the National Institute on Alcohol Abuse and Alcoholism binge-on-chronic alcohol feeding (NIAAA) model, both of which aim to mimic the early stages of human ALD. Statistical analysis showed that total BA levels did not change significantly in either model. However, unconjugated BAs were elevated in both models, and glycol-conjugated BAs were significantly increased only in the NIAAA model. The deconjugation capacity of ursodeoxycholic acid (UDCA) and β-muricholic acid (β-MCA) was increased in the CLD model, whereas that of cholic acid (CA) and lithocholic acid (LCA) was increased in the NIAAA model. NIAAA mice showed increased FXR affinity, implying that the classical biosynthetic pathway of hepatic BAs was inhibited. In conclusion, although total BA levels remained unchanged in the early stages of ALD in both models, the BA composition was more altered in the NIAAA model than in the CLD model, suggesting that different ALD mouse models may exhibit divergent regulatory mechanisms for BA metabolism.

Indexed as

AlcoholismBile Acids and SaltsLiverAnimalsChromatography, LiquidDisease Models, AnimalEthanolLiver Diseases, AlcoholicMaleMass SpectrometryMiceMice, Inbred C57BLBile Acids and SaltsEthanolAlcohol-associated liver diseaseBile acidsLC-MSMetabolomicsMouse model comparison

Identifiers

PMID40413821
PMCPMC12140870

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.